The global sales of dialysis equipment are estimated to be worth USD 11,126.0 million in 2024 and anticipated to reach a value of USD 17,780.9 million by 2034. Sales are projected to rise at a CAGR of 4.8% over the forecast period between 2024 and 2034. The revenue generated by dialysis equipment in 2023 was USD 10,616.4 million.
A significant pool of patients suffering from end-stage renal disease (ESRD) which poses as a major health concern globally requires dialysis for the filtration of contaminants from kidneys and lead a sustainable life.
The main etiological factor for the increased prevalence of ESRD is the increasing chronic diseases of type 2 diabetes and hypertension. If these are not controlled with medications, these diseases cause progressive slow damage to kidneys, finally leading to ESRD. The other major factors are the aging population; elderly adults are more prone to have reduced renal function with complications related to that.
Global Dialysis Equipment Market Assessment
Attributes | Key Insights |
---|---|
Historical Size, 2023 | USD 10,616.4 million |
Estimated Size, 2024 | USD 11,126.0 million |
Projected Size, 2034 | USD 17,780.9 million |
Value-based CAGR (2024 to 2034) | 4.8% |
With advanced medical technologies leveraging end-stage renal disease to increased life expectancy with filtration of waste materials form kidney. This has resulted in an increase demand for dialysis for a number of patients who need long-term treatment or kidney transplantation.
The risk of developing and living with kidney disease becomes even more difficult in geographical areas that have poor access to healthcare services. It underlines the demand for increasing infrastructure, medical resources, and public health efforts as a way to mitigate the rising incidence of ESRD among vulnerable populations.
A rise in life expectancy increases the burden of age-related diseases like CKD. Older adults are more predisposed to kidney damage because of a physiologic decrease in renal function with older age, in addition to the cumulative effects of chronic diseases. Demographic shifts towards older populations have significantly contributed to an increasing demand for dialysis services and kidney transplantation.
There is high burden of ESRD, driven by chronic diseases, aging populations, lifestyle factors, and healthcare disparities, that has had the greatest influence on demand for dialysis equipment.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The above table presents the expected CAGR for the global Dialysis Equipment Market over several semi-annual periods spanning from 2024 to 2034. In the first half (H1) of the decade from 2023 to 2033, the business is predicted to surge at a CAGR of 5.9%, followed by a slightly higher growth rate of 5.3% in the second half (H2) of the same decade.
Particular | Value CAGR |
---|---|
H1 | 5.9% (2023 to 2033) |
H2 | 5.5% (2023 to 2033) |
H1 | 4.8% (2024 to 2034) |
H2 | 4.4% (2024 to 2034) |
The above table presents the expected CAGR for the global dialysis equipment market over several semi-annual periods spanning from 2024 to 2034. In the first half (H1) of the decade from 2023 to 2033, the business is predicted to surge at a CAGR of 5.9%, followed by a slightly lower growth rate of 5.5% in the second half (H2) of the same decade.
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to decrease slightly to 4.8% in the first half and increase moderately at 4.4% in the second half. In the first half (H1) the market witnessed a decrease of -70.00 BPS while in the second half (H2), the market witnessed an decreases of -90.00 BPS.
Rising Demand for Dialysis among the Aging Population is a driver for Dialysis Equipment Market
One of the major driving factors for the dialysis equipment market is certainly the growing demand for dialysis from the aging population. With growing old age, there is a corresponding surge in the prevalence of chronic kidney disease and end-stage renal disease hence, the requirement for the adoption of more improved and comprehensive dialysis solutions increases.
For instance, the World Health Organization has made projections indicating that the percentage of the world's population that will be 60 years of age or older by mid this century will double and peg at
Improved healthcare has led to increased life expectancy, and more people live longer but not necessarily in perfect health. Much as longevity might be an expected and welcome outcome, it also presents the higher risk of age-related diseases like CKD. The more years one lives, the higher the chances of requiring dialysis at some point or the other. In turn, this definitely leads to a higher demand for dialysis clinics, home dialysis alternatives, and the necessary equipment.
While the aging population has greatly fueled the dialysis equipment market, it also comes with its challenges. The high expenses for dialysis treatments and trained health care workers who monitor the treatment are very significant difficulties.
In a way, these difficulties create opportunities for innovations. Indeed, in that respect, the market witnesses growth in the development of new cost-effective and efficient solutions able not only to minimize the burden on healthcare systems but also to improve patient outcomes.
The Increasing Prevalence of End Stage Renal Disease Program (ESRD) as driver for Dialysis Equipment
ESRD is one of the major healthcare problems globally. One of the drivers of demand for advanced dialysis equipment arises from ESRD. This is a very critical condition, and it manifests as permanent kidney failure and is thus fatal unless the patient is on dialysis or was transplanted. Statistics indicate that its prevalence has risen over the past couple of decades with large underlying drivers.
According to American Kidney Fund, up to 37 million Americans have kidney disease. Nearly 808,000 Americans are living with kidney failure. More than 557,000 Americans are on dialysis. Kidney disease is increasing at an alarming rate.
It currently affects greater than 1 in 7 or 14% of American adults. In 2021, there were about 135,000 new cases of kidney failure among Americans. Nine out of ten people with kidney disease are unaware they have it, and one in three of those with severely reduced kidney function have no awareness of their kidney disease but are not yet on dialysis.
ESRD, driven by the prevalence of chronic diseases, ageing populations, and lifestyle factors, is growing in ascending trends and is expected ultimately to have a significant influence on the demand for dialysis equipment. This trend impresses on three critical needs: continued innovation, investment in healthcare infrastructure, and global collaboration to combat the growing burden of kidney diseases worldwide.
Growing Awareness about Kidney Health Propelling the Growth of Dialysis Equipment Market
Awareness programs on kidney health have been engaged in by different organizations and healthcare bodies. For example, World Kidney Day is an annual event aware of kidney health and attempts at reducing the incidence and consequences of kidney disease and its complications.
Accordingly, numerous programs aimed at sensitizing risk factors of kidney disease, diabetes, hypertension, and obesity, as well as unhealthy lifestyles, have been implemented and encouraged people to live healthier and regularly check on them. This therefore stressed early detection and more lately, some general screening programs were affected. Evidence of CKD will allow timely institution of interventions early in people with CKD hence slowing down the progression of CKD to ESRD.
Growing awareness has also led to planning and implementation of chronic disease management programs where kidney health forms a significant concern. These facilities are intended to control and reduce the risk factors of kidney disease by making lifestyle changes, managing medication, and providing continuous monitoring.
One of the major drivers for the dialysis equipment market is increasing awareness about kidney health. With increasing awareness, the market for dialysis equipment will grow accordingly so as to provide adequate treatment for patients who suffer from CKD and ESRD.
Dialysis equipment, including machines and consumables, is costly to manufacture and maintain
The operations of dialysis machines are pretty complex; hence, sophisticated technology is required. They have to filter and cleanse the blood correctly; this requires sophisticated engineering and high-precision components. Here is where the complexity of the machines calls for specialized materials and highly developed techniques of production, which will greatly increase the cost.
Since dialysis treatment is a very critical process, the equipment has to meet very stringent specifications of safety and quality. Since such equipment must adhere to the compliance requirements of the regulatory bodies, like FDA or European CE, a protracted process of testing and validation is needed. These regulatory compliance requirements increase the cost of production due to extended research, development, and quality control.
Components, such as pumps, filtration units, and sensors, in dialysis machines are normally fabricated from expensive materials that are highly durable and reliable. It is these components, along with the need for precision engineering, that sets the biggest share of the total cost in the manufacturing of dialysis machines.
Dialysis equipment requires constant maintenance to be always kept in top condition and to extend their life span, but routine checks, servicing, and periodic replacement of parts that have a finite lifetime are also required. This has the implication of increasing operational costs for hospitals/dialysis centers through investment in competent technicians and the necessity of maintenance contracts.
It is mostly the high costs of production and maintenance that limit accessibility to the treatment of dialysis equipment in most cases, especially in low- and middle-income countries. In tight healthcare budgets, the cost of purchasing and servicing dialysis machines may be unaffordable and therefore creates inequalities in access to this life-saving intervention.
The global dialysis equipment industry recorded a CAGR of 3.9% during the historical period between 2019 and 2023. The growth of dialysis equipment industry was positive as it reached a value of USD 18,760.8 million in 2023 from USD 15,462.8 billion in 2019.
Increasing chronic diseases like metabolic diseases and hypertension, are significantly driving the dialysis equipment market. The growing burden of such chronic diseases underlines all the more the critical role that dialysis equipment can play in managing ESRD by dispensing life-sustaining therapies to these patients. This further pushes the innovation in dialysis technology efficiency, patient comfort, and accessibility with respect to the growing demand for healthcare due to chronic kidney diseases around the world.
Hypertension also plays a monumental role in causing progressive kidney damage, further increasing the need for renal replacement therapy. Owing to the above-mentioned chronic conditions that act simultaneously within a body, effective dialysis solutions still remain crucial for the huge number of patients reporting with the diseases.
The growing burden of such chronic diseases underlines, all the more, the critical role dialysis equipment can play in the management of ESRD, providing life-sustaining therapies to these patients. This further pushes innovation in dialysis technology efficiency, patient comfort, and accessibility about the growing demand for healthcare due to chronic kidney diseases around the world.
Tier 1 companies comprise market leaders with a market revenue of above USD 100 million capturing significant market share of 54.4% in global market. These companies invest in advanced research and development to innovate new technologies that enhance treatment efficacy and improve patient outcomes.
Expanding global market presence is another key strategy, often achieved through strategic partnerships, acquisitions, and establishing strong distribution networks. Prominent companies within tier 1 include Baxter, Asahi Kasei Corporation, Fresenius Medical Care AG & Co. KGaA and Cantel Medical.
Tier 2 companies include mid-size players with revenue of USD 50 to 100 million having presence in specific regions and highly influencing the local market and holds around 6.1% market share. These companies often differentiate themselves through niche product offerings or specialized services that cater to specific segments of the market. Prominent companies in tier 2 include Rockwell Medical, JMS Co.Ltd., Teleflex Incorporated, B. Braun Melsungen AG and NIPRO.
Finally, Tier 3 companies, such as HEMOCLEAN CO., LTD., Quanta and Outset Medical, Inc. are essential for the market. They specialize in specific products and cater to niche markets, adding diversity to the industry.
Overall, while Tier 1 companies are the primary drivers of the market, Tier 2 and 3 companies also make significant contributions, ensuring the dialysis equipment market remains dynamic and competitive.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section below covers the industry analysis for the dialysis equipment market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Asia Pacific, Europe, and others, is provided. The United States is anticipated to remain at the forefront in North America, with higher market share through 2034. In Asia Pacific, China is projected to witness a CAGR of 6.6% by 2034.
Countries | Value CAGR (2024 to 2034) |
---|---|
USA | 3.6% |
Canada | 5.0% |
China | 6.6% |
Germany | 4.3% |
France | 4.7% |
India | 5.1% |
Australia | 4.4% |
South Korea | 4.5% |
USA Dialysis Equipment Market is poised to exhibit a CAGR of 1.5% between 2024 and 2034. Currently, it holds the highest share in the North American market, and the trend is expected to continue during the forecast period.
The high prevalence of CKD and ESRD cases in the United States makes the country an important part of the global dialysis equipment market. These have been related to diabetes and hypertension, thus demanding better technologies and treatment options today across the country.
Moreover, the USA health care system has advanced medical infrastructure and huge investments in health care technology. The country's regulatory frameworks in terms of safety, efficacy, and quality further sustain a competitive market landscape where companies strive to bring leading-edge dialysis products and services into healthcare facilities for the betterment of care and treatment outcomes.
Germany holds around prominent share of the Western Europe dialysis equipment industry. China’s market is anticipated to grow at a CAGR of 4.3% throughout the forecast period.
Several factors contribute to the central role Germany plays in the global dialysis equipment market. Germany has a well-structured healthcare system known for the high standards of its medical care and innovation. It creates an environment that supports extensive research and development of medical-related technologies, including that of advanced and efficient dialysis equipment.
The specific driving factor for dialysis equipment, however, remains the very high prevalence of chronic kidney diseases in Germany. Chronic kidney disease is among the major health concerns witnessed in the country. This demands effective, reliable dialysis treatment.
Germany is one of the countries with a large prevalence of chronic kidney disease and end-stage renal disease, due mainly to demographic factors such as aging populations and lifestyle diseases like diabetes and hypertension. These demographic trends drive demands for dialysis equipment and services throughout this country.
China’s dialysis equipment market is poised to exhibit a CAGR of 6.6% between 2024 and 2034. Currently, it holds the highest share in the Asia Pacific market, and the trend is expected to continue during the forecast period.
The Chinese government's policies for developing the medical device industry naturally include dialysis equipment. Initiatives like "Made in China 2025" and subsidization related to researching and developing medical technologies boost the development of capabilities and market expansion for domestic companies.
While supportive government policies and healthcare reform initiatives aimed at increasing access to medical services raise the level of dialysis treatments that are affordable and available, these factors place China as a key and growing market on the global stage for dialysis equipment.
In addition, over the years, China has been able to develop a solid domestic base for the manufacturing of dialysis equipment. The major Chinese firms have emerged from this protectionist system to become major actors in the global market, as Fresenius Medical Care China, B.Braun Medical, and Shenzhen Medico are among the key firms involved in the leading Chinese companies.
The section contains information about the leading segments in the industry. By Product, the haemodialysis devices segment holds the highest market share of 59.6% in 2024.
By Product | Haemodialysis Devices |
---|---|
Value Share (2024) | 59.8% |
Hemodialysis devices, due to their wide adoption in treating end-stage renal disease cases, consequently hold a higher market share, thereby leading the market. The devices are mainly preferred because of their efficacy in waste products and excess fluid removal from the blood, imitating kidney functions. Their established record, coupled with technological advancements that have improved treatment efficiency and better compatibility with healthcare infrastructure globally, drives them to the top.
Hemodialysis devices have been considered cost-effective for the treatment of CKD and ESRD, compared to other modalities such as peritoneal dialysis or kidney transplantation. Thus, being the relatively less expensive and proven effective, hemodialysis has come up to be the most prevalent modality for the aforementioned treatment, thus encouraging the demand for hemodialysis equipment.
Besides, device manufacturing companies keep constantly innovating to increase device reliability, patient comfort, and operational efficiency, which easily tags them as the first choice for renal replacement therapy and justifies greater market share in the hemodialysis devices segment.
Disease Condition | Chronic |
---|---|
Value Share (2024) | 70.1% |
One of the major disease conditions that is expected to boost the dialysis machines market is chronic disease especially chronic kidney disease (CKD) is a progressive condition whereby the functioning of kidneys goes down progressively with time, generally due to other underlying health problems like diabetes, hypertension, and aging demographics. Patients suffering from CKD progress to ESRD and hence require regular dialysis for the removal of waste products and excess fluids from the blood.
The two major conditions that lead to chronic diseases are diabetes and high blood pressure. Already, chronic kidney disease is highly prevalent across the globe for which the number of dialysis-requiring patients continues to increase mainly due to the rapidly growing diabetes rate and hypertension in the population. Diabetes and hypertension shared a highly occupational track and stand as two major risk factors for CKD.
Substantial investments are seen in the dialysis equipment industry towards research and development in order to drive innovations by differentiating products through advanced features and improved patient outcomes. Another key strategic focus of these companies is to actively look for strategic partners to bolster their product portfolios and expand their global market presence.
Recent Industry Developments in Dialysis Equipment Market:
In terms of product, the industry is divided into haemodialysis devices (haemodialysis machines, dialyzers and filters, vascular access devices), peritoneal dialysis devices (dialyzers and filters, vascular access devices) and continuous renal replacement therapy.
In terms of disease condition, the industry is segregated into chronic and acute.
In terms of end use, the industry is segregated into hospitals, clinics, ambulatory surgical centres and home care settings.
Key countries of North America, Latin America, Western Europe, Eastern, South Asia and Pacific, East Asia and Middle East and Africa (MEA) have been covered in the report.
The global dialysis equipment market is projected to witness CAGR of 4.8% between 2024 and 2034.
The global dialysis equipment industry stood at USD 18,760.8 million in 2023.
The global dialysis equipment industry is anticipated to reach USD 31,448.4 million by 2034 end.
India is set to record the highest CAGR of 4.8% in the assessment period.
The key players operating in the global dialysis equipment industry include Baxter, Asahi Kasei Corporation, Fresenius Medical Care AG & Co. KGaA, Cantel Medical, B. Braun Melsungen AG and NIPRO are the key manufacturers of dialysis equipment market.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-Economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 5.1. By Product 5.2. By Disease Condition 5.3. By End Use 5.4. By Region 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product 6.1. Haemodialysis Devices 6.1.1. Haemodialysis Machines 6.1.2. Dialyzers and Filters 6.1.3. Vascular Access Devices 6.2. Peritoneal Dialysis Devices 6.2.1. Dialyzers and Filters 6.2.2. Vascular Access Devices 6.3. Continuous Renal Replacement Therapy 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Disease Condition 7.1. Chronic 7.2. Acute 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End Use 8.1. Hospital 8.2. Clinics 8.3. Ambulatory Surgical Centers 8.4. Home Care Settings 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 9.1. North America 9.2. Latin America 9.3. East Asia 9.4. South Asia and Pacific 9.5. Western Europe 9.6. Eastern Europe 9.7. Middle East and Africa 10. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 11. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 12. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 13. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. Middle East and Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. Sales Forecast 2024 to 2034 By Product, By Disease Condition and By End Use for 30 Countries 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 19. Company Profile 19.1. Baxter 19.2. Asahi Kasei Corporation 19.3. Fresenius Medical Care AG & Co. KGaA 19.4. Cantel Medical 19.5. Rockwell Medical 19.6. JMS Co.Ltd. 19.7. Teleflex Incorporated 19.8. B. Braun Melsungen AG 19.9. NIPRO 19.10. HEMOCLEAN CO., LTD. 19.11. Quanta 19.12. Outset Medical, Inc.
Explore Healthcare Insights
View Reports